vemurafenib prodrugs (Sunshine Lake Pharmaceutical/Calitor Sciences)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namevemurafenib prodrugs (Sunshine Lake Pharmaceutical/Calitor Sciences)
Drug Alias NameCT-317CT-207
ClassificationSmall molecules
Mechanisms of ActionSerine/threonine-protein kinase B-raf inhibitorsAnticancer protein kinase inhibitors
TargetsSerine/threonine-protein kinase B-raf
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesGuangdong Hec Technology Holding Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCalitor Sciences LlcGuangdong Hec Technology Holding Co Ltd
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A